Chemed Corp (CHE) stock
CHENYSEServices-Home Health Care ServicesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 17/306% above fair value
$546.72−0.03 (-0.01%)
Close on Nov 18, 2026Market cap $7.12BP/E 26.1Yield 0.40%
Chemed gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Chemed's gross profit for the twelve months ending Sep 30, 2026 was $892.52M, up 6.9% year over year. For fiscal 2025 it was $823.18M, down 3.6% from the year before. Over ten years it grew 6.1% a year on average. The highest annual figure on record is $854.35M in fiscal 2024.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $823.18M | -3.6% |
| FY2024 | Dec 31, 2024 | $854.35M | +7.0% |
| FY2023 | Dec 31, 2023 | $798.82M | +4.4% |
| FY2022 | Dec 31, 2022 | $765.09M | -0.6% |
| FY2021 | Dec 31, 2021 | $769.80M | +9.8% |
| FY2020 | Dec 31, 2020 | $701.39M | +13.6% |
| FY2019 | Dec 31, 2019 | $617.43M | +11.2% |
| FY2018 | Dec 31, 2018 | $555.00M | +7.5% |
| FY2017 | Dec 31, 2017 | $516.19M | +11.9% |
| FY2016 | Dec 31, 2016 | $461.45M | +1.2% |
| FY2015 | Dec 31, 2015 | $455.78M | +8.1% |
| FY2014 | Dec 31, 2014 | $421.61M | +4.2% |
| FY2013 | Dec 31, 2013 | $404.52M | +2.0% |
| FY2012 | Dec 31, 2012 | $396.72M | +2.9% |
| FY2011 | Dec 31, 2011 | $385.49M | +2.9% |
| FY2010 | Dec 31, 2010 | $374.53M | +5.3% |
| FY2009 | Dec 31, 2009 | $355.66M | +5.1% |
| FY2008 | Dec 31, 2008 | $338.39M | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $232.96M | +16.6% |
| Q2 FY2026 | Jun 30, 2026 | $221.47M | +19.9% |
| Q1 FY2026 | Mar 31, 2026 | $215.76M | -0.3% |
| Q4 FY2025 | Dec 31, 2025 | $222.32M | -5.0% |
| Q3 FY2025 | Sep 30, 2025 | $199.76M | -4.9% |
| Q2 FY2025 | Jun 30, 2025 | $184.69M | -10.4% |
| Q1 FY2025 | Mar 31, 2025 | $216.41M | +6.0% |
| Q4 FY2024 | Dec 31, 2024 | $234.12M | +2.9% |
| Q3 FY2024 | Sep 30, 2024 | $209.99M | +3.9% |
| Q2 FY2024 | Jun 30, 2024 | $206.13M | +14.8% |
| Q1 FY2024 | Mar 31, 2024 | $204.11M | +7.7% |
| Q4 FY2023 | Dec 31, 2023 | $227.57M | +15.5% |
| Q3 FY2023 | Sep 30, 2023 | $202.17M | +12.6% |
| Q2 FY2023 | Jun 30, 2023 | $179.62M | -7.6% |
| Q1 FY2023 | Mar 31, 2023 | $189.45M | -2.3% |
| Q4 FY2022 | Dec 31, 2022 | $197.08M | -3.7% |
| Q3 FY2022 | Sep 30, 2022 | $179.54M | -8.6% |
| Q2 FY2022 | Jun 30, 2022 | $194.47M | +7.0% |
| Q1 FY2022 | Mar 31, 2022 | $194.00M | +3.8% |
| Q4 FY2021 | Dec 31, 2021 | $204.65M | +3.2% |
| Q3 FY2021 | Sep 30, 2021 | $196.50M | +3.9% |
| Q2 FY2021 | Jun 30, 2021 | $181.76M | +21.1% |
| Q1 FY2021 | Mar 31, 2021 | $186.89M | +13.9% |
| Q4 FY2020 | Dec 31, 2020 | $198.24M | +13.3% |
| Q3 FY2020 | Sep 30, 2020 | $189.06M | +24.0% |
| Q2 FY2020 | Jun 30, 2020 | $150.04M | +0.1% |
| Q1 FY2020 | Mar 31, 2020 | $164.05M | +17.1% |
| Q4 FY2019 | Dec 31, 2019 | $174.97M | +20.3% |
| Q3 FY2019 | Sep 30, 2019 | $152.43M | +9.8% |
| Q2 FY2019 | Jun 30, 2019 | $149.95M | +10.2% |
| Q1 FY2019 | Mar 31, 2019 | $140.08M | +4.0% |
| Q4 FY2018 | Dec 31, 2018 | $145.45M | +6.3% |
| Q3 FY2018 | Sep 30, 2018 | $138.84M | +7.3% |
| Q2 FY2018 | Jun 30, 2018 | $136.07M | +5.3% |
| Q1 FY2018 | Mar 31, 2018 | $134.64M | +11.5% |
| Q4 FY2017 | Dec 31, 2017 | $136.86M | +10.0% |
| Q3 FY2017 | Sep 30, 2017 | $129.40M | – |
| Q2 FY2017 | Jun 30, 2017 | $129.21M | – |
| Q1 FY2017 | Mar 31, 2017 | $120.72M | – |
| Q4 FY2016 | Dec 31, 2016 | $124.39M | – |
See a number that looks wrong?